840-P: Lower Health-Care Utilization among Diverse Adolescents and Young Adults (AYA) Who Receive Culturally Discordant Care

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 840-P
Author(s):  
JAQUELIN J. FLORES GARCIA ◽  
JENNIFER RAYMOND ◽  
SHIVANI AGARWAL ◽  
ALEJANDRA TORRES SANCHEZ ◽  
MARK W. REID
Keyword(s):  
Health Care ◽  
Young Adults ◽  
Health Care Utilization ◽  
Adolescents And Young Adults ◽  
Care Utilization ◽  
Lower Health

Inpatient Health Care Utilization in the United States Among Children, Adolescents, and Young Adults With Nephrotic Syndrome

2013 ◽  
Vol 61 (6) ◽  
pp. 910-917 ◽  
Author(s):  
Debbie S. Gipson ◽  
Kassandra L. Messer ◽  
Cheryl L. Tran ◽  
Emily G. Herreshoff ◽  
Joyce P. Samuel ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Young Adults ◽  
Nephrotic Syndrome ◽  
Health Care Utilization ◽  
The United States ◽  
Adolescents And Young Adults ◽  
Care Utilization

Health care utilization among homeless adolescents and young adults

2003 ◽  
Vol 32 (4) ◽  
pp. 253-256 ◽  
Author(s):  
S BARKIN ◽  
R BALKRISHNAN ◽  
J MANUEL ◽  
R ANDERSEN ◽  
L GELBERG
Keyword(s):  
Health Care ◽  
Young Adults ◽  
Health Care Utilization ◽  
Adolescents And Young Adults ◽  
Care Utilization ◽  
Homeless Adolescents

Disease activity and health-care utilization among young adults with childhood-onset lupus transitioning to adult care: data from the Pediatric Lupus Outcomes Study

Lupus ◽  
2020 ◽  
Vol 29 (10) ◽  
pp. 1206-1215
Author(s):  
Sara L Haro ◽  
Erica F Lawson ◽  
Aimee O Hersh
Keyword(s):  
Health Care ◽  
Young Adults ◽  
Health Care Utilization ◽  
Disease Activity ◽  
Care Utilization ◽  
Childhood Onset ◽  
Adult Care ◽  
Medication Usage ◽  
Pediatric Lupus ◽  
Outcomes Study

Background Individuals with childhood-onset systemic lupus erythematosus (cSLE) must transfer from pediatric to adult care. The goal of this study was to examine disease activity and health-care utilization among young adults with cSLE who are undergoing or have recently completed the transfer to adult care. Methods The Pediatric Lupus Outcomes Study (PLOS) is a prospective longitudinal cohort study of young adults aged 18–30 diagnosed with cSLE. We conducted a cross-sectional analysis comparing 47 participants under the care of pediatric rheumatologists to 38 who had completed transfer to adult care. Demographics, disease manifestations, health- care utilization and transition readiness were compared between groups. Results Those in the post-transfer group had significantly lower medication usage and were less likely to have seen a rheumatologist in the past year. Disease manifestations, flare rates, and hospitalizations were similar between groups. Nearly a quarter of patients who had transferred to adult care reported difficulties with the process. Conclusion Post-transfer patients had lower health-care utilization as evidenced by less medication usage and lack of rheumatology follow-up, in spite of the fact that disease activity was similar in both groups. Future studies will assess longitudinal changes in disease activity and damage in this population.

scholarly journals Young Adults' Health Care Utilization and Expenditures Prior to the Affordable Care Act

2014 ◽  
Vol 54 (6) ◽  
pp. 663-671 ◽  
Author(s):  
Josephine S. Lau ◽  
Sally H. Adams ◽  
W. John Boscardin ◽  
Charles E. Irwin
Keyword(s):  
Health Care ◽  
Young Adults ◽  
Health Care Utilization ◽  
Affordable Care Act ◽  
Care Utilization ◽  
The Affordable Care Act

scholarly journals Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder

2017 ◽  
Vol 7 (3) ◽  
pp. 106-110 ◽  
Author(s):  
Allison Beatty ◽  
Christopher Stock
Keyword(s):  
Health Care ◽  
Alcohol Use ◽  
Health Care Utilization ◽  
Alcohol Use Disorder ◽  
Randomized Trials ◽  
Emergency Department Visits ◽  
Care Utilization ◽  
Oral Naltrexone ◽  
Lower Health ◽  
Long Acting

Abstract Introduction: Approximately 17 million Americans and 300 000 veterans have an alcohol use disorder (AUD). Both oral naltrexone (NTX) and long-acting, injectable naltrexone (LAI NTX) are FDA-approved to treat AUD. LAI NTX is often reserved for patients with adherence concerns due to considerable differences in drug cost and administration requirements. To date, there are no randomized trials comparing efficacy of LAI NTX to oral NTX. This retrospective cohort study compared clinical outcomes in veterans treated with LAI NTX or oral NTX. Methods: Health care utilization in veterans at 1 Veterans Affairs facility treated for AUD with oral NTX and LAI NTX was compared. The primary outcome was 90-day alcohol-related hospital admissions per patient (ARA90). Secondary outcomes included 90-day outpatient clinic and emergency department visits and 30-day alcohol-related admissions (ARA30). Inclusion criteria included first-time prescription of NTX for AUD from January 1, 2015, through December 1, 2015. Veterans receiving concurrent acamprosate or disulfiram were excluded. Results: Seventy-nine patients were included with 65 in the oral NTX group and 14 in the LAI NTX group. The ARA90 was 0.17 for the oral NTX group and 0.64 for the LAI NTX group (P = .06). The oral NTX group had significantly fewer ARA30 than the LAI NTX group (P < .01). Oral NTX also had significantly lower health care utilization for all other parameters. Discussion: Oral NTX was associated with lower health care utilization compared to LAI NTX in this veteran population. This indicates that LAI NTX may not provide additional benefit justifying the cost. This study had several limitations. Randomized trials comparing efficacy between oral NTX and LAI NTX are needed.

Sign in / Sign up

Export Citation Format

Share Document